0
Skip to Content
Bluestein Ventures
Home
Our Focus
Work With Us
Team
Insights
Portfolio
Bluestein Ventures
Home
Our Focus
Work With Us
Team
Insights
Portfolio
Home
Our Focus
Work With Us
Team
Insights
Portfolio
Provi Surpassed $5B in GMV Flowing Through Its Platform
Portfolio News Intern Bluestein Ventures 11/18/25 Portfolio News Intern Bluestein Ventures 11/18/25

Provi Surpassed $5B in GMV Flowing Through Its Platform

Read More
People Science Launches Chloe LiveLab, A New Collaborative Ingredient-Brand Research Model
Portfolio News Intern Bluestein Ventures 11/4/25 Portfolio News Intern Bluestein Ventures 11/4/25

People Science Launches Chloe LiveLab, A New Collaborative Ingredient-Brand Research Model

Read More
BiomeSense Closed an Oversubscribed $7M Round
Portfolio News Intern Bluestein Ventures 10/20/25 Portfolio News Intern Bluestein Ventures 10/20/25

BiomeSense Closed an Oversubscribed $7M Round

Read More
ALTR Highlighted as a Top Startup Shaping the N/A Beverage Market
Portfolio News Intern Bluestein Ventures 9/11/25 Portfolio News Intern Bluestein Ventures 9/11/25

ALTR Highlighted as a Top Startup Shaping the N/A Beverage Market

Read More
ALTR Secures a $5M Seed Round and was Featured in Forbes
Portfolio News Intern Bluestein Ventures 7/14/25 Portfolio News Intern Bluestein Ventures 7/14/25

ALTR Secures a $5M Seed Round and was Featured in Forbes

Read More
Crafty Announced a Major Strategic Partnership with Staples
Portfolio News Intern Bluestein Ventures 6/17/25 Portfolio News Intern Bluestein Ventures 6/17/25

Crafty Announced a Major Strategic Partnership with Staples

Read More
Lembas GLP-1 Ingredient Manufacturer Enters The Market Following $3.6 Million Pre-Seed Investment
Portfolio News Intern Bluestein Ventures 6/10/25 Portfolio News Intern Bluestein Ventures 6/10/25

Lembas GLP-1 Ingredient Manufacturer Enters The Market Following $3.6 Million Pre-Seed Investment

Read More
Milamend Co-Founder Mila Magnani was Featured in Forbes
Portfolio News Bluestein Associates 4/15/25 Portfolio News Bluestein Associates 4/15/25

Milamend Co-Founder Mila Magnani was Featured in Forbes

Read More
Fount Launched Flykitt Fit for On-Demand Workouts for Frequent Flyers
Portfolio News Bluestein Associates 4/3/25 Portfolio News Bluestein Associates 4/3/25

Fount Launched Flykitt Fit for On-Demand Workouts for Frequent Flyers

Read More
Attane Health Launched a New Partnership with Anthem Blue Cross Blue Shield of Kentucky
Portfolio News Bluestein Associates 4/1/25 Portfolio News Bluestein Associates 4/1/25

Attane Health Launched a New Partnership with Anthem Blue Cross Blue Shield of Kentucky

Read More
Rugiet CEO Mike Apostal Wrote an Article for Forbes Outlining How Direct-To-Patient Models Are Redefining Care
Portfolio News Intern Bluestein Ventures 3/17/25 Portfolio News Intern Bluestein Ventures 3/17/25

Rugiet CEO Mike Apostal Wrote an Article for Forbes Outlining How Direct-To-Patient Models Are Redefining Care

Read More
New Culture’s Animal-Free Mozzarella has Generated $5M in Early Demand Ahead of Commercial Debut
Portfolio News Bluestein Associates 3/11/25 Portfolio News Bluestein Associates 3/11/25

New Culture’s Animal-Free Mozzarella has Generated $5M in Early Demand Ahead of Commercial Debut

Read More
Bizzy was Recognized as one of Bain’s 120 High-Growth Consumer Products Brands of 2025
Portfolio News Bluestein Associates 3/1/25 Portfolio News Bluestein Associates 3/1/25

Bizzy was Recognized as one of Bain’s 120 High-Growth Consumer Products Brands of 2025

Read More
Crafty Secures $10M Funding Round Through Partnership with JLL and JLL Spark Global Ventures
Portfolio News Bluestein Associates 11/14/24 Portfolio News Bluestein Associates 11/14/24

Crafty Secures $10M Funding Round Through Partnership with JLL and JLL Spark Global Ventures

Read More
Jellatech Expands Bioidentical Human Collagen Production at New 9,000-Square-Foot Facility
Portfolio News Bluestein Associates 11/6/24 Portfolio News Bluestein Associates 11/6/24

Jellatech Expands Bioidentical Human Collagen Production at New 9,000-Square-Foot Facility

Read More
Attane Health Selected for Unreasonable Impact Americas Program
Portfolio News Bluestein Associates 10/17/24 Portfolio News Bluestein Associates 10/17/24

Attane Health Selected for Unreasonable Impact Americas Program

Read More
Chowly’s CEO, Sterling Douglass, and CRO, Tom Lawton, Recognized by Pavilion as Top Leaders to Watch in 2024
Portfolio News Bluestein Associates 9/9/24 Portfolio News Bluestein Associates 9/9/24

Chowly’s CEO, Sterling Douglass, and CRO, Tom Lawton, Recognized by Pavilion as Top Leaders to Watch in 2024

Read More
Aerflo Featured in Fast Company as a Game-Changer in the Beverage Industry
Portfolio News Bluestein Associates 8/27/24 Portfolio News Bluestein Associates 8/27/24

Aerflo Featured in Fast Company as a Game-Changer in the Beverage Industry

Read More
Older Posts

Stay in the loop

Join our quarterly newsletter.

Thank you!
BIconFooter2.png
 

Meet with us
415 N LaSalle Drive, Suite 700A
Chicago, IL 60654

Talk with us
Inquire here
312.724.8788

Linkedin Logo
Twitter Logo

 


©Bluestein Ventures, All Rights Reserved